E.I. Gubanova
Research Subjects
E.I. Gubanova has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Maria I. Glushkova
Estelab Clinic LLC
2 shared publications - Yulia Yu. Chebotareva
Estelab Clinic LLC; Russian Medical Academy of Continuous Professional Education
2 shared publications - Artjom Ivanov
Technoesthetics LLC, Moscow, Russia
1 shared publication - Ekaterina G. Privalova
Estelab Clinic LLC
1 shared publication - Elena V. Vladimirova
Federal State Budgetary Institution FNCC of the FMBA of Russia
1 shared publication - P.A. Starovatova
Vallex Med Clinic
1 shared publication
Latest Publications
- 22 September 2026
- Published by Russian Biotechnological University (ROSBIOTECH) in Bulletin of the Medical Institute of Continuing Education
- Vol. 6 (4)
THE COS-SIM SIMULATOR FOR COSMETOLOGIST AND PLASTIC SURGEON
Background. In recent years, there has been a noticeable increase in demand for training in the specialties of "Cosmetology" and "Plastic Surgery". One of the important skills for specialists is performing injection procedures on the face - botulinum toxin and fillers. Interest in simulationbased training for doctors in aesthetic medicine is driven by the global shift in medical education towards patient safety, artificial intelligence, and digitalization. This underscores the need to introduce innovative simulators into the educational process - simulators that allow for the effective acquisition of the necessary skills on a realistic phantom, while deepening knowledge of anatomy and the anatomical risks associated with facial procedures. Purpose. To present the possibilities of innovative training for doctors using a simulator to master the skills of injection procedures in cosmetology and plastic surgery. Main content. The Cos-Sim simulator is a phantom of the human head and neck with a realistic model of soft tissues, equipped with unique software that allows you to master the skills of injection procedures, study the layer-by-layer anatomy of the head and neck and realistically approach the development of minimally invasive manipulations, preparation for accreditation and the ability to work with patients. The target audience is residents in the specialties "Dermatovenerology" and "Plastic Surgery", cosmetologists, dermatologists and plastic surgeons, medical accreditation centers, medical universities, educational medical centers, as well as manufacturing companies of drugs, medical devices and equipment. The article presents the main modules of simulation training for CosSim: injection of botulinum toxin end fillers, the navigation system and the anatomy atlas, as well as the experience and advantages of simulation training. Conclusion. The CosSim simulator is a unique tool for training specialists and enhances the credibility and value of course training in injection techniques. For young doctors - it provides a safe practice environment; for practicing specialists - it offers the opportunity to master complex techniques and improve the accuracy of performing new and standard techniques on the face and neck without risk for patients.
- 22 September 2026
- Published by Russian Biotechnological University (ROSBIOTECH) in Bulletin of the Medical Institute of Continuing Education
- Vol. 6 (4)
THE COS-SIM SIMULATOR FOR COSMETOLOGIST AND PLASTIC SURGEON
Background. In recent years, there has been a noticeable increase in demand for training in the specialties of "Cosmetology" and "Plastic Surgery". One of the important skills for specialists is performing injection procedures on the face - botulinum toxin and fillers. Interest in simulationbased training for doctors in aesthetic medicine is driven by the global shift in medical education towards patient safety, artificial intelligence, and digitalization. This underscores the need to introduce innovative simulators into the educational process - simulators that allow for the effective acquisition of the necessary skills on a realistic phantom, while deepening knowledge of anatomy and the anatomical risks associated with facial procedures. Purpose. To present the possibilities of innovative training for doctors using a simulator to master the skills of injection procedures in cosmetology and plastic surgery. Main content. The Cos-Sim simulator is a phantom of the human head and neck with a realistic model of soft tissues, equipped with unique software that allows you to master the skills of injection procedures, study the layer-by-layer anatomy of the head and neck and realistically approach the development of minimally invasive manipulations, preparation for accreditation and the ability to work with patients. The target audience is residents in the specialties "Dermatovenerology" and "Plastic Surgery", cosmetologists, dermatologists and plastic surgeons, medical accreditation centers, medical universities, educational medical centers, as well as manufacturing companies of drugs, medical devices and equipment. The article presents the main modules of simulation training for CosSim: injection of botulinum toxin end fillers, the navigation system and the anatomy atlas, as well as the experience and advantages of simulation training. Conclusion. The CosSim simulator is a unique tool for training specialists and enhances the credibility and value of course training in injection techniques. For young doctors - it provides a safe practice environment; for practicing specialists - it offers the opportunity to master complex techniques and improve the accuracy of performing new and standard techniques on the face and neck without risk for patients.
- 18 August 2026
- Published by Russian Biotechnological University (ROSBIOTECH) in Bulletin of the Medical Institute of Continuing Education
- Vol. 6 (3)
MODERN METHODS FOR HAND REJUVENATION. OWN SCIENTIFIC AND CLINICAL EXPERIENCE OF INJECTION PROCEDURES
Background. Treatment of the markers of aging of the hand requires the use of multidirectional methods that ensure the improvement of skin quality, replenishment of soft tissue volume, elimination of signs of photodamage. Modern injection and hardware methods aimed at the prevention and treatment of age-related skin changes are widely represented. However, research papers devoted to the effectiveness and safety of methods of correction of the back of the hand, especially long-term results, are not enough in the scientific literature. Purpose. To present a brief overview of the most frequently used minimally invasive hand rejuvenation procedures, filler injections, and their associated complications. Materials and methods. An analysis of 29 selected publications from a literature review on hand ageing and rejuvenation, as well as device-based and injectable procedures for the dorsum of the hands, was conducted. The authors' own scientific and clinical experience in correcting age-related changes of the dorsal hands is presented. Results. Hand ageing markers and hand ageing morphotypes are presented, taking into account anatomical, constitutional, and age-related characteristics. The successful scientific and clinical experience of foreign experts using device-based and injectable methods is provided, along with a summary of the authors' own studies with illustrated results (from 3 to 12 months) prove the high efficacy of filler injections based on hyaluronic acid (HA), polylactic acid, and calcium hydroxylapatite. The risks of rare late complications (product visibility/contouring, granulomas) and post-procedure adverse events (AEs: edema, erythema, contouring, ecchymosis) are described. The authors present safe cannula and needle techniques, recommending the subcutaneous layer (2–3 mm above the dorsal superficial fascia) for filler injection, and dermal or subdermal layers (1–3 mm) for skinboosters. Recommended dosages are limited to no more than 1.0 mL per hand per procedure, alongside structured treatment courses and combined protocols. Conclusion. Despite the limited number of studies concerning hand rejuvenation, injections of fillers and skinboosters based on HA, calcium hydroxylapatite, and polylactic acid represent effective and safe methods for correcting age-related changes in the hands.
- 18 August 2026
- Published by Russian Biotechnological University (ROSBIOTECH) in Bulletin of the Medical Institute of Continuing Education
- Vol. 6 (3)
MODERN METHODS FOR HAND REJUVENATION. OWN SCIENTIFIC AND CLINICAL EXPERIENCE OF INJECTION PROCEDURES
Background. Treatment of the markers of aging of the hand requires the use of multidirectional methods that ensure the improvement of skin quality, replenishment of soft tissue volume, elimination of signs of photodamage. Modern injection and hardware methods aimed at the prevention and treatment of age-related skin changes are widely represented. However, research papers devoted to the effectiveness and safety of methods of correction of the back of the hand, especially long-term results, are not enough in the scientific literature. Purpose. To present a brief overview of the most frequently used minimally invasive hand rejuvenation procedures, filler injections, and their associated complications. Materials and methods. An analysis of 29 selected publications from a literature review on hand ageing and rejuvenation, as well as device-based and injectable procedures for the dorsum of the hands, was conducted. The authors' own scientific and clinical experience in correcting age-related changes of the dorsal hands is presented. Results. Hand ageing markers and hand ageing morphotypes are presented, taking into account anatomical, constitutional, and age-related characteristics. The successful scientific and clinical experience of foreign experts using device-based and injectable methods is provided, along with a summary of the authors' own studies with illustrated results (from 3 to 12 months) prove the high efficacy of filler injections based on hyaluronic acid (HA), polylactic acid, and calcium hydroxylapatite. The risks of rare late complications (product visibility/contouring, granulomas) and post-procedure adverse events (AEs: edema, erythema, contouring, ecchymosis) are described. The authors present safe cannula and needle techniques, recommending the subcutaneous layer (2–3 mm above the dorsal superficial fascia) for filler injection, and dermal or subdermal layers (1–3 mm) for skinboosters. Recommended dosages are limited to no more than 1.0 mL per hand per procedure, alongside structured treatment courses and combined protocols. Conclusion. Despite the limited number of studies concerning hand rejuvenation, injections of fillers and skinboosters based on HA, calcium hydroxylapatite, and polylactic acid represent effective and safe methods for correcting age-related changes in the hands.
- 18 August 2026
- Published by Russian Biotechnological University (ROSBIOTECH) in Bulletin of the Medical Institute of Continuing Education
- Vol. 6 (3)
LONG-TERM USE OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF AXILLARY HYPERHIDROSIS: CHANGES IN THE DURATION OF EFFECT WITH REPEATED COURSES
Background. Currently, the use of botulinum toxin type A (BoNT-A) is a popular, safe, and highly effective therapy for primary axillary hyperhidrosis (AHG). This article describes the results of long-term observation of the use of botulinum toxin type A (BoNT-A) for the treatment of AHG. The clinical observations were conducted in two medical centers in Russia, which confirm global studies on the increased duration of the treatment effect for axillary hyperhidrosis with repeated courses of therapy. Purpose. Аnalyzes data on the duration of the effect depending on the drug dose and the number of courses performed. The aim of the work is to evaluate the dynamics of the duration of the clinical effect and the degree of reduction of the AGG sweating during multiple courses of therapy BoNT-A based on a retrospective analysis of the clinical use of the drug. Materials and methods. Retrospective analysis (over 6 years) of outpatient cards and questionnaires of 278 patients of the cosmetology profile aged 25-55 years (mean age 39.9 + 8.43) who underwent repeated (at least 6 courses ) therapy of axillary hyperhidrosis with the neuroprotein AboBTX-A. The results after each course of therapy were evaluated after 1,3,6,9,12 months. The following methods were used to evaluate the results: the GAIS patient satisfaction scale, hydrometry, the Dermatology Life Quality Index (DLQI), the Hyperhidrosis Disease Severity Scale (HDSS), and the Minor test. Results. An analysis of the results of axillary hyperhidrosis treatment with AboBTX-A showed high satisfaction with the results in 99% of patients during the entire follow-up period. The accumulated data indicate that botulinum toxin type A is an effective and safe method for long-term control of axillary hyperhidrosis]. Of particular interest is the phenomenon of increased duration of the clinical effect after repeated courses of therapy. The most convincing data demonstrate an increase in the median duration of effect from 5.5 to 9 +2.3 months with repeated courses of therapy. The practical significance of this phenomenon lies in reducing the frequency of procedures, increasing adherence to treatment, improving the quality of life of patients. Conclusion. The high efficacy and safety of AboBTX-A therapy for axillary hyperhidrosis have been proven. Repeated courses of therapy not only maintain efficacy, but can also increase the duration of clinical remission.
- 18 August 2026
- Published by Russian Biotechnological University (ROSBIOTECH) in Bulletin of the Medical Institute of Continuing Education
- Vol. 6 (3)
LONG-TERM USE OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF AXILLARY HYPERHIDROSIS: CHANGES IN THE DURATION OF EFFECT WITH REPEATED COURSES
Background. Currently, the use of botulinum toxin type A (BoNT-A) is a popular, safe, and highly effective therapy for primary axillary hyperhidrosis (AHG). This article describes the results of long-term observation of the use of botulinum toxin type A (BoNT-A) for the treatment of AHG. The clinical observations were conducted in two medical centers in Russia, which confirm global studies on the increased duration of the treatment effect for axillary hyperhidrosis with repeated courses of therapy. Purpose. Аnalyzes data on the duration of the effect depending on the drug dose and the number of courses performed. The aim of the work is to evaluate the dynamics of the duration of the clinical effect and the degree of reduction of the AGG sweating during multiple courses of therapy BoNT-A based on a retrospective analysis of the clinical use of the drug. Materials and methods. Retrospective analysis (over 6 years) of outpatient cards and questionnaires of 278 patients of the cosmetology profile aged 25-55 years (mean age 39.9 + 8.43) who underwent repeated (at least 6 courses ) therapy of axillary hyperhidrosis with the neuroprotein AboBTX-A. The results after each course of therapy were evaluated after 1,3,6,9,12 months. The following methods were used to evaluate the results: the GAIS patient satisfaction scale, hydrometry, the Dermatology Life Quality Index (DLQI), the Hyperhidrosis Disease Severity Scale (HDSS), and the Minor test. Results. An analysis of the results of axillary hyperhidrosis treatment with AboBTX-A showed high satisfaction with the results in 99% of patients during the entire follow-up period. The accumulated data indicate that botulinum toxin type A is an effective and safe method for long-term control of axillary hyperhidrosis]. Of particular interest is the phenomenon of increased duration of the clinical effect after repeated courses of therapy. The most convincing data demonstrate an increase in the median duration of effect from 5.5 to 9 +2.3 months with repeated courses of therapy. The practical significance of this phenomenon lies in reducing the frequency of procedures, increasing adherence to treatment, improving the quality of life of patients. Conclusion. The high efficacy and safety of AboBTX-A therapy for axillary hyperhidrosis have been proven. Repeated courses of therapy not only maintain efficacy, but can also increase the duration of clinical remission.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (3) , 497-506
Ultrasound and morphological characteristics of the lower face tissue changes in the submandibular and submental regions after the use of cryolipolysis and its combination with microfocused ultrasound
Background. Cryolipolysis (CL) is a non-invasive technique that provides selective reduction of adipocyte number. At the same time, understanding of the specific changes in the skin and subcutaneous adipose tissue when using combined protocols, for example with microfocused ultrasound (MFUS), is insufficient. Therefore, there is a need for a more detailed study of structural changes in tissues with various therapeutic approaches. Objective. To evaluate morphological and ultrasound changes in the skin in the submental and submandibular regions after the use of CL and its combination with MFUS. Material and methods. Ultrasound was performed before hardware methods (D01), after 3, 6 and 12 months (M03, M06 and M12, respectively) in 30 patients (15 patients from each group). Histological examination was done in 6 patients (3 patients from each group). In the 1st group (CL), a repeat biopsy was taken 3 months after the CL procedure (M03). In the 2nd group (CL+MFUS with visualization), re-sampling was performed twice: 3 months after CL (M03) and 3 months after MFUS with visualization (M06). Results. In the CL+MFUS-V group, a tendency towards increased dermal thickness and a decrease in subcutaneous fat thickness was observed. In the CL group, similar changes were recorded on M03 while the impact was the same, but later the severity of changes decreased. According to morphometric analysis, both methods demonstrate comparable effectiveness, while the combined impact is characterized by more pronounced dynamics of changes. Conclusion. The obtained results indicate the potential of a combined approach for correcting changes in the lower face.
- 3 July 2026
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 25 (3) , 497-506
Ultrasound and morphological characteristics of the lower face tissue changes in the submandibular and submental regions after the use of cryolipolysis and its combination with microfocused ultrasound
Background. Cryolipolysis (CL) is a non-invasive technique that provides selective reduction of adipocyte number. At the same time, understanding of the specific changes in the skin and subcutaneous adipose tissue when using combined protocols, for example with microfocused ultrasound (MFUS), is insufficient. Therefore, there is a need for a more detailed study of structural changes in tissues with various therapeutic approaches. Objective. To evaluate morphological and ultrasound changes in the skin in the submental and submandibular regions after the use of CL and its combination with MFUS. Material and methods. Ultrasound was performed before hardware methods (D01), after 3, 6 and 12 months (M03, M06 and M12, respectively) in 30 patients (15 patients from each group). Histological examination was done in 6 patients (3 patients from each group). In the 1st group (CL), a repeat biopsy was taken 3 months after the CL procedure (M03). In the 2nd group (CL+MFUS with visualization), re-sampling was performed twice: 3 months after CL (M03) and 3 months after MFUS with visualization (M06). Results. In the CL+MFUS-V group, a tendency towards increased dermal thickness and a decrease in subcutaneous fat thickness was observed. In the CL group, similar changes were recorded on M03 while the impact was the same, but later the severity of changes decreased. According to morphometric analysis, both methods demonstrate comparable effectiveness, while the combined impact is characterized by more pronounced dynamics of changes. Conclusion. The obtained results indicate the potential of a combined approach for correcting changes in the lower face.
- 22 June 2026
- Published by Russian Biotechnological University (ROSBIOTECH) in Bulletin of the Medical Institute of Continuing Education
- Vol. 6 (2)
EFFICACY OF CRYOLIPOLYSIS AND ITS COMBINATION WITH MICROFOCUSED ULTRASOUND IN THE CORRECTION OF AGE-RELATED CHANGES IN THE LOWER THIRD OF THE FACE AND SUBMANDIBULAR AREA: A PROSPECTIVE COMPARATIVE COHORT STUDY
Background. Cryolipolysis (CL) and microfocused ultrasound with visualization (MFU-V) are effective and safe methods for the correction of excessive subcutaneous fat (SCF) in the submental and submandibular areas. However, data on the effectiveness of their combined use in the lower third of the face remain limited. Purpose. To evaluate the efficacy of cryolipolysis as monotherapy and in combination with MFU-V for improving skin quality and reducing subcutaneous fat volume. Materials and methods. A prospective multicenter comparative non-randomized cohort study included 108 patients aged 35–65 years. Participants were divided into two groups: group 1 (CL, n=54) received cryolipolysis only; group 2 (CL+MFU-V, n=54) received cryolipolysis followed by MFU-V after 3 months. Treatment efficacy was assessed using GAIS, SCF severity scales, caliper measurements, and the total aging index (TAI). Results. Both groups demonstrated a statistically significant reduction in SCF severity and skinfold thickness. The combined protocol was associated with more pronounced improvements in several parameters. The most notable differences between the groups were observed at 6 months and persisted up to 12 months. Conclusion. The combined use of cryolipolysis and MFU-V provides a more pronounced and sustained clinical effect compared to monotherapy.
- 22 June 2026
- Published by Russian Biotechnological University (ROSBIOTECH) in Bulletin of the Medical Institute of Continuing Education
- Vol. 6 (2)
EFFICACY OF CRYOLIPOLYSIS AND ITS COMBINATION WITH MICROFOCUSED ULTRASOUND IN THE CORRECTION OF AGE-RELATED CHANGES IN THE LOWER THIRD OF THE FACE AND SUBMANDIBULAR AREA: A PROSPECTIVE COMPARATIVE COHORT STUDY
Background. Cryolipolysis (CL) and microfocused ultrasound with visualization (MFU-V) are effective and safe methods for the correction of excessive subcutaneous fat (SCF) in the submental and submandibular areas. However, data on the effectiveness of their combined use in the lower third of the face remain limited. Purpose. To evaluate the efficacy of cryolipolysis as monotherapy and in combination with MFU-V for improving skin quality and reducing subcutaneous fat volume. Materials and methods. A prospective multicenter comparative non-randomized cohort study included 108 patients aged 35–65 years. Participants were divided into two groups: group 1 (CL, n=54) received cryolipolysis only; group 2 (CL+MFU-V, n=54) received cryolipolysis followed by MFU-V after 3 months. Treatment efficacy was assessed using GAIS, SCF severity scales, caliper measurements, and the total aging index (TAI). Results. Both groups demonstrated a statistically significant reduction in SCF severity and skinfold thickness. The combined protocol was associated with more pronounced improvements in several parameters. The most notable differences between the groups were observed at 6 months and persisted up to 12 months. Conclusion. The combined use of cryolipolysis and MFU-V provides a more pronounced and sustained clinical effect compared to monotherapy.